Clinnovate Health | Publications
Clinnovate Health partners with medtech and healthcare technology providers to build and commercialise novel integrative diagnostic platforms for various research and clinical applications.
clinnovate health, clinnovatehealth, Medtech and Healthcare Technology Providers, Research, Clinical Applications
page-template-default,page,page-id-16395,ajax_fade,page_not_loaded,,qode-theme-ver-7.9,wpb-js-composer js-comp-ver-4.11.1,vc_responsive


Title: Quantitative imaging and characterization of collagen patterns in high grade serous ovarian carcinoma (HGSOC)

Huang Ruby et al


Type: Poster

Event: Sept 28 2019, ESMO Tumor Biology and Pathology: 2010P. Session 1: 12:00-13:00 at Poster Area (Hall 4)

Title: A novel nutritional supplement prevents muscle loss and accelerates muscle mass recovery in caloric-restricted mice

Anita M. van den Hoek et al (2019), Metabolism, doi:10.1016/j.metabol.2019.05.012


Type: Paper Publication

Title: Multi-photon Microscopy for Characterization of Renal Cell Carcinoma Pseudocapsule: Implications for Tumour Enucleation

Tan Yi Quan, Tay Wy Keat, Ooi Li Yin, Teo Zui Chih Rachel, Tiong Ho Yee


Type: Poster

Event: European Association of Urology 2019, Barcelona (Poster #1196)

Title: Comparison of Various Quantitative and Qualitative Collagen Analysis Methods in Early Liver Fibrosis   

Reinout Stoop, Martine Morrison, Serene Lek, Arianne van Koppen, Lars Verschuren, Nicky van Trigt, Natascha van Lent, Roeland Hanemaaijer


Type: Poster

Event: Keystone Symposia 2019 (Integrated Pathways of Disease in NASH and NAFLD), Sante Fe

Title: Application of Human NASH-based Transcriptome and Metabolome Profiles in Preclinical Models for the Translational Study of Drug Effects on Liver Fibrosis

 Morrison MC, Verschuren L, Salic K, vanden Hoek AM, Menke A, Verheij J, Iruarrizaga-Lejarreta M, Turner S, Schwerk A, van Koppen A, Wielinga P Y, Mato JM, Hanemaaijer R, Alonso C, Kleemann R.


Type: Poster

Event: AASLD HistoIndex Breakfast Meeting 2018

Title: Icosabutate, a novel structurally engineered fatty-acid, exhibits potent anti-inflammatory and anti-fibrotic effects in a dietary mouse model resembling progressive human NASH

David A Fraser, Xiaoyu Wang, Cristina Alonso, Serene Lek, Tore Skjaeret, Detlef Schuppan


Type: Poster

Event: AASLD 2018, San Francisco (Poster #1300)

Title: Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice

Morrison, M. C. et al (2018), Hepatology Communications. doi: 10.1002/hep4.1270


Type: Paper Publication

Title: Phenotypical characterization of intrahepatic cholangiocarcinomas stroma : The more fibrous, The less pejorative

L. Blaise, M. Albuquerque, C. Neuzillet, N. Guedj, J. Cros, V. Paradis

INSERM UMR1149 Beaujon Hospital, Clichy, France


Type: Poster

Event: AASLD 2016, Boston